Evaluation of Pharmacist-led Medication Reconciliation Service Benefits in

Status Terminated

Clinical Trial Summary

Background: Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk. Objective: The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise. The main questions to be answered were: - the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge - the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge. Participants in the intervention group were offered the following: - medication reconciliation on admission - medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists. Participants in the control group were offered standard care.

Clinical Trial Description

Design: pragmatic, prospective, controlled clinical trial Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia: - one intervention ward with a routine pharmacist-led medication reconciliation service - four control wards Data collection: - Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients. - Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation. - The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity. - Patient comorbidity was assessed using the Charlson Comorbidity Index - For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records - Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview. ;

Study Design

Related Conditions & MeSH terms

Medication Reconciliation

Clinical Trial Details

NCT number	NCT06207500
Study type	Interventional
Source	The University Clinic of Pulmonary and Allergic Diseases Golnik
Contact
Status	Terminated
Phase	N/A
Start date	September 30, 2019
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03670433` - Medication Reconciliation for Patients Over 65 Years Old : Cost Analysis of the Process Implemented in the Polyvalent Internal Medical Unit of Rennes University Hospital
Completed	`NCT03666793` - Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care	N/A
Completed	`NCT01179867` - Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge	N/A
Completed	`NCT02223676` - Clinical Pharmacists in the Emergency Department	N/A
Completed	`NCT01226589` - Pharmacist Discharge Medication Reconciliation Study	N/A
Completed	`NCT01195051` - Medication Reconciliation Technology to Improve Quality of Transitional Care	Phase 3
Completed	`NCT02905474` - Mobile Health Technology for Chronic Kidney Disease Patients: Medication Management	N/A
Completed	`NCT00296426` - Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital	N/A
Recruiting	`NCT04796142` - Medication Reconciliation in Oncologic Patients	N/A
Completed	`NCT03029052` - Medication Reconciliation at Discharge: Impact on Patient's Care	N/A
Terminated	`NCT01065675` - Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)	N/A
Completed	`NCT02289469` - PictureRx: Improving Medication Safety in Health Disparity Populations	N/A
Completed	`NCT03955965` - Medication Reconciliation in an Emergency Department: How to Prioritize Patients ?

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Pharmacist-led Medication Reconciliation Service Benefits in Hospitalised Medical Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms